News

Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease
Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...
The Harvard Crimson47m
Researchers Develop New Broad-Spectrum Coronavirus Drug at Harvard’s Wyss Institute
Researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering have developed a compound that could work as a ...